Skip to content
The Kids Research Institute Australia logo
Donate

Discover . Prevent . Cure .

Search

News & Events

ATAR exams – special provisions

End-of-year exams may be far from the minds of students managing diabetes but now is the time to get the process started for obtaining special ATAR provisions.

News & Events

Managing the rise in glucose levels after meals

With more families using continuous glucose monitoring, many people are asking what they can do to reduce the rise in glucose levels after meals.

News & Events

Understanding the relationship between insulin and carbs

Researchers are on the hunt for young people with Type 1 Diabetes to participate in a short at-home trial looking at insulin and carbs.

News & Events

Welcome to the team

Meet Kelly – the latest addition to the PMH Diabetes and Endocrinology clinic.

News & Events

DiAthlete Gavin Griffiths talks with ABC Radio

London Olympics torchbearer Gavin Griffiths is living proof that a Type 1 Diabetes diagnosis is no obstacle to making the most out of life.

Research

Transition models of care for type 1 diabetes: a systematic review

Managing the care regimen for Type 1 Diabetes is challenging for emerging adults, as they take on greater responsibility for self-management. A diverse range of models of care have been implemented to improve safety and quality of care during transition between paediatric and adult services. However, evidence about acceptability and effectiveness of these is limited.

Research

Impact of Body Composition on the Accuracy of a Medtronic Guardian Continuous Glucose Monitoring System

Continuous glucose monitoring systems are used in therapeutic decisions for diabetes management, however, the impact of body composition on CGM accuracy is not known. Body composition variables were collected in an observational study designed to determine the accuracy of an investigational Medtronic Guardian™ sensor 3.

Research

The Cost of Control: Cost-effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth

Hybrid closed-loop (HCL) therapy is an efficacious management strategy for young people with type 1 diabetes. However, high costs prevent equitable access. We thus sought to evaluate the cost-effectiveness of HCL therapy compared with current care among young people with type 1 diabetes in Australia.